US Broker Ratings

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -15.68% Potential Downside Amid Revenue Challenges

As a key player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has been at the forefront of mRNA technology, revolutionizing how the world approaches vaccines and therapeutics. However, recent..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unpacking a Potential 37.5% Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is drawing significant attention from investors with its robust potential upside of 37.52%, as indicated by its average target price of $176.89 against a current..

Eli Lilly and Company (LLY) Stock Analysis: Exploring a 19.98% Potential Upside in the Healthcare Giant

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio in pharmaceuticals. With a market capitalization nearing the trillion-dollar..

Alkermes plc (ALKS) Stock Analysis: A Strong Buy with 37% Potential Upside

Individual investors eyeing opportunities in the biopharmaceutical sector may find Alkermes plc (NASDAQ: ALKS) a compelling consideration. As a leading player in the healthcare industry, Alkermes focuses on developing innovative..

Bio-Techne Corp (TECH) Stock Analysis: Uncovering the 30.82% Potential Upside for Investors

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, presents an intriguing investment opportunity with a significant potential upside of 30.82%. This Minneapolis-based biotechnology company specializes in developing,..

Option Care Health, Inc. (OPCH) Stock Analysis: Analyst Ratings Highlight Growth Potential with a 11.57% Upside

For investors with a keen eye on the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents an intriguing opportunity, especially in the niche of home and alternate site infusion..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the genomics sector, stands at an intriguing juncture for investors. With a market capitalization of $17.99 billion, the company is a key..

Ascendis Pharma A/S (ASND) Investor Outlook: Biotech Growth with 25.95% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biotechnology sector, is capturing attention with its significant growth potential and a market cap of $13.81 billion. Based in Hellerup,..

AptarGroup, Inc. (ATR) Stock Analysis: Discovering the 11.29% Upside Potential

AptarGroup, Inc. (NYSE: ATR) is a noteworthy player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. With a market capitalization of $9.52 billion, the company has..

UnitedHealth Group (UNH) Stock Analysis: An Insight Into Its 25.73% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable entity in the healthcare sector, with a towering market capitalization of $262.69 billion. Operating through its diverse segments — UnitedHealthcare, Optum..

Baxter International Inc. (BAX) Stock Analysis: Navigating Through Challenges with Strategic Resilience

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, continues to capture the attention of investors with its expansive portfolio of medical instruments and supplies. Headquartered in Deerfield,..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Powerhouse with a Strong Growth Trajectory

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a testament to enduring success in the medical distribution industry. With a current market capitalization of $116.94 billion,..

Charles River Laboratories (CRL) Stock Analysis: A 16.86% Upside Amidst Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector, has been on the radar of investors due to its significant contributions to the diagnostics and..

Solventum Corporation (SOLV) Stock Analysis: Exploring a Potential 22% Upside in the Healthcare Sector

Solventum Corporation (SOLV), a prominent player in the healthcare sector, is capturing investor attention with its innovative solutions across medical instruments and supplies. With a market capitalization of $12.65 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating the Diagnostic Frontier with a 2.3% Upside Potential

Exact Sciences Corporation (NASDAQ: EXAS) is carving a niche for itself in the healthcare sector with its innovative cancer screening and diagnostic products. With a market capitalization of $19.74 billion,..

Amgen Inc. (AMGN): Investor Outlook on a Healthcare Giant with a 2.58% Dividend Yield

Amgen Inc. (NASDAQ: AMGN) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $202.02 billion, Amgen’s presence is undeniably..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Leader with 8.11% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL) stands as a beacon in the biotechnology sector, renowned for its focus on developing novel therapies for challenging cancer types. Headquartered in Alameda, California, Exelixis has..

Insulet Corporation (PODD) Stock Analysis: A 46.51% Potential Upside Amid Strong Revenue Growth

Investors with a keen eye on the healthcare sector might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect, particularly given its robust revenue growth and the promising outlook from analysts...

Chemed Corp (CHE) Stock Analysis: Healthcare Service Leader Eyes 16.85% Potential Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is drawing investor attention with its robust service offerings and a notable potential upside of 16.85%. Headquartered in Cincinnati,..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings and a Potential 12% Upside for This Medical Device Innovator

Investors eyeing the healthcare sector might want to take a closer look at Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic pharmaceuticals and medical technology. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds